MYOM2 and rheumatic heart disease: Even though GAS vaccines based on the GAS’s virulence factor, M protein, have been developed [28,29], the safety issue due to autoreactive rheumatic heart disease by repeat immunization with recombinant M protein needs to be reassessed [30].